TimesSquare Capital Management LLC Has $20.16 Million Stock Position in HealthEquity, Inc. (NASDAQ:HQY)

TimesSquare Capital Management LLC lowered its stake in HealthEquity, Inc. (NASDAQ:HQY) by 43.3% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 304,078 shares of the company’s stock after selling 232,000 shares during the quarter. TimesSquare Capital Management LLC’s holdings in HealthEquity were worth $20,160,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently made changes to their positions in the company. FMR LLC lifted its stake in shares of HealthEquity by 19.1% during the 3rd quarter. FMR LLC now owns 5,648,992 shares of the company’s stock worth $412,659,000 after buying an additional 907,743 shares during the last quarter. Mackenzie Financial Corp lifted its position in HealthEquity by 58.2% during the fourth quarter. Mackenzie Financial Corp now owns 1,807,407 shares of the company’s stock worth $119,831,000 after acquiring an additional 664,979 shares during the last quarter. Invesco Ltd. boosted its holdings in shares of HealthEquity by 164.6% during the third quarter. Invesco Ltd. now owns 484,043 shares of the company’s stock worth $35,359,000 after acquiring an additional 301,078 shares during the period. Clearbridge Investments LLC grew its position in shares of HealthEquity by 12.1% in the third quarter. Clearbridge Investments LLC now owns 2,204,675 shares of the company’s stock valued at $161,051,000 after purchasing an additional 238,116 shares during the last quarter. Finally, Eagle Asset Management Inc. bought a new position in shares of HealthEquity during the third quarter worth approximately $15,581,000. Institutional investors own 99.55% of the company’s stock.

HealthEquity Stock Down 2.1 %

NASDAQ HQY traded down $1.60 on Friday, hitting $75.85. 24,945 shares of the company were exchanged, compared to its average volume of 589,287. The company has a current ratio of 4.76, a quick ratio of 4.76 and a debt-to-equity ratio of 0.43. The company has a market cap of $6.51 billion, a PE ratio of 121.02, a PEG ratio of 1.28 and a beta of 0.55. The stock has a fifty day moving average of $80.46 and a 200-day moving average of $74.77. HealthEquity, Inc. has a 12 month low of $53.58 and a 12 month high of $84.49.

HealthEquity (NASDAQ:HQY) last released its quarterly earnings data on Tuesday, March 19th. The company reported $0.50 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.42 by $0.08. The company had revenue of $262.39 million for the quarter, compared to analysts’ expectations of $258.56 million. HealthEquity had a net margin of 5.57% and a return on equity of 6.91%. As a group, analysts forecast that HealthEquity, Inc. will post 2.12 earnings per share for the current year.

Analyst Ratings Changes

A number of equities research analysts have recently issued reports on the stock. JPMorgan Chase & Co. boosted their target price on shares of HealthEquity from $86.00 to $108.00 and gave the company an “overweight” rating in a research report on Tuesday, April 2nd. JMP Securities assumed coverage on shares of HealthEquity in a report on Thursday, April 4th. They issued a “mkt outperform” rating and a $101.00 price objective for the company. Barrington Research reaffirmed an “outperform” rating and set a $100.00 target price on shares of HealthEquity in a report on Friday, March 22nd. BTIG Research raised their price target on HealthEquity from $100.00 to $110.00 and gave the stock a “buy” rating in a research report on Wednesday, March 20th. Finally, Royal Bank of Canada upped their target price on HealthEquity from $90.00 to $92.00 and gave the stock an “outperform” rating in a research note on Wednesday, March 20th. One analyst has rated the stock with a hold rating and eleven have issued a buy rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $96.17.

Insider Buying and Selling at HealthEquity

In other news, EVP Delano Ladd sold 2,558 shares of the company’s stock in a transaction that occurred on Friday, March 1st. The stock was sold at an average price of $82.59, for a total transaction of $211,265.22. Following the transaction, the executive vice president now directly owns 47,438 shares of the company’s stock, valued at $3,917,904.42. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. In other HealthEquity news, EVP Delano Ladd sold 2,558 shares of HealthEquity stock in a transaction dated Friday, March 1st. The stock was sold at an average price of $82.59, for a total transaction of $211,265.22. Following the completion of the transaction, the executive vice president now owns 47,438 shares in the company, valued at approximately $3,917,904.42. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Jon Kessler sold 33,765 shares of the stock in a transaction that occurred on Friday, March 22nd. The stock was sold at an average price of $79.81, for a total value of $2,694,784.65. Following the completion of the sale, the chief executive officer now directly owns 126,635 shares of the company’s stock, valued at $10,106,739.35. The disclosure for this sale can be found here. Over the last quarter, insiders sold 68,823 shares of company stock valued at $5,482,975. Company insiders own 2.70% of the company’s stock.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.